HIF1A and neoplasm: Our studies indicated that Pt(IV)Ac‐POA effectively maintains or reduces basal levels of HIF1α, even in tumour cells with resistance characteristics that otherwise show increased HIF1α in response to Cisplatin, suggesting that other pathways might be involved in the complex interplay between hypoxia, cell death, and drug resistance.